M
Multicell Technologies Inc
OTC:MCET
Multicell Technologies Inc
OTC:MCET
Price:
0
USD
Market Closed
Market Cap:
$0
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Multicell Technologies Inc
OTC:MCET
|
US |
|
N
|
Nanosphere Health Sciences Inc
CNSX:NSHS
|
US |
|
P
|
Piramal Pharma Ltd
NSE:PPLPHARMA
|
IN |
|
Tigers Realm Coal Ltd
ASX:TIG
|
AU |
|
Lenta Plc
LSE:LNTA
|
RU |
|
N
|
Neptis SA
WSE:YAN
|
PL |
|
S
|
Shinsung Delta Tech Co Ltd
KOSDAQ:065350
|
KR |
|
E
|
EDP Renovaveis SA
ELI:EDPR
|
ES |
|
C
|
Consorcio Ara SAB de CV
BMV:ARA
|
MX |
|
O
|
Olympic Circuit Technology Co Ltd
SSE:603920
|
CN |
|
D
|
DaedongGear
KOSDAQ:008830
|
KR |
|
T
|
Thai Union Group PCL
SET:TU
|
TH |
|
HCP Plastene Bulkpack Ltd
BSE:526717
|
IN |
|
Water Ways Technologies Inc
XTSX:WWT
|
CA |
|
Harris Technology Group Ltd
ASX:HT8
|
AU |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of MCET.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MCET
Multiples-Based Value
Not Available
Multiples Across Competitors
MCET Competitors Multiples
Multicell Technologies Inc Competitors
Multicell Technologies Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Multicell Technologies Inc
OTC:MCET
|
5k USD | 0 | -0 | 0.7 | 0.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD | 6.1 | 88.8 | 14.7 | 20.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.6 | 17.7 | 13.2 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 12.3 | 39.5 | 42.8 | 43.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 32.6 | 11 | 13.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
